Companies: 10,795·Total market cap: $144.5T
Monopar Therapeutics Inc.

Monopar Therapeutics Inc.

MNPRNASDAQHealthcare● Active
$60.61
+$1.13(+1.90%)
Market Cap$406030027
P/E Ratio
52W High$105
52W Low$29.18

Monopar Therapeutics Inc. (MNPR) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · MNPR · as of Mar 27, 2026

Latest filing snapshot

22
+6+37.50%vs prior year

Monopar Therapeutics Inc. (MNPR) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
22
Change (1Y)
+6
Growth % (1Y)
+37.50%
Revenue / Employee
Net Income / Employee
$-623.5K
Market Cap
$406M

MNPR Employee Count

2017 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-2722+6+37.50%
2025-03-3116+6+60.00%
2024-03-2810-2-16.67%
2023-03-2312+2+20.00%
2022-03-2410+0+0.00%
2021-03-2510+3+42.86%
2020-03-277+2+40.00%
2019-02-265+0+0.00%
2018-03-265

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Bicycle Therapeutics plc
BCYC
Bicycle Therapeutics plc
305
#2
4D Molecular Therapeutics, Inc.
FDMT
4D Molecular Therapeutics, Inc.
227
#3
Akebia Therapeutics, Inc.
AKBA
Akebia Therapeutics, Inc.
181
#4
Gossamer Bio, Inc.
GOSS
Gossamer Bio, Inc.
144
#5
Fulcrum Therapeutics, Inc.
FULC
Fulcrum Therapeutics, Inc.
45
#6
Compass Therapeutics, Inc.
CMPX
Compass Therapeutics, Inc.
35
#7
Monopar Therapeutics Inc.
MNPR
Monopar Therapeutics Inc.YOU
22
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · MNPR peer comparison

About MNPR employees

MNPR Employees · Headcount

Monopar Therapeutics Inc. (MNPR) employee data is sourced from the annual SEC 10-K filing. As of 2025, Monopar Therapeutics Inc. had 22 full-time employees globally. Full-time employees only. Global consolidated headcount.

Monopar Therapeutics Inc.'s workforce increased by 6 (37.50%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Frequently Asked Questions

MNPR Employees · 5 questions

As of the latest SEC 10-K filing (2025), Monopar Therapeutics Inc. had 22 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Monopar Therapeutics Inc. employee counthow many employees does Monopar Therapeutics Inc. haveMNPR total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-27